Interview: Oussama Badad: Chief Scientific Officer: Growmics
About the Author: HCN News Team
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Related Posts
Latest News
Curaleaf Raises Bid to Acquire Aurora Cannabis
STAMFORD – Curaleaf Holdings Inc. announced it will file a notice to increase its acquisition offer for Aurora Cannabis Inc. to US$5.00 per share. Under the enhanced terms, Aurora shareholders would receive 0.4013 Curaleaf shares ...
Ohio Sets New Package and Potency Limits for Cannabis Products
COLUMBUS – The Ohio Department of Commerce Division of Cannabis Control adopted the rule, which applies to products intended for direct sale to recreational consumers and medical patients. It generally bars products from exceeding 90% ...
Curaleaf Secures Australian Approval for Medical Cannabis Inhaler, Lists in New Zealand
LONDON – Curaleaf International, part of Curaleaf Holdings, Inc., in partnership with Jupiter Research LLC, announced that its Que Medical Inhalation Device (QMID) has been registered by Australia's Therapeutic Goods Administration (TGA) as a Class ...
